Boston Scientific to Acquire Advanced Bionics for $740 Billion

In a transaction that will add implantable microelectronic devices to its product line, Boston Scientific Corp. (Natick, MA, USA) has agreed to acquire Advanced Bionics (Valencia, CA, USA) for around U.S.$740 million in cash plus earn-out payments based on future performance milestones.

Advanced Bionics has developed microstimulation devices to treat tremor and epilepsy, Parkinson's disease, urinary incontinence, lower back pain, and hearing loss. The company is a leading manufacturer of cochlear implants. Its neurostimulation devices treat neurologic conditions through the delivery of focused electrical current to targeted nerve fibers. The devices are wirelessly controlled by a doctor or the patient to deliver the precise timing and amount of electrical current needed to overcome the patient's disabling condition.

"The acquisition by Boston Scientific allows us to build on their global sales and marketing experience,” said Al Mann, co-CEO of Boston Scientific. "I believe the combination of the Advanced Bionics technology platforms and the Boston Scientific entrepreneurial philosophy is capable of achieving tremendous outcomes for patients and doctors.”




Related Links:
Boston Scientific
Advanced Bionics